지분 5% 초과 신고

The information set forth in Item 4 of the Schedule 13D is amended as follows: Effective as of the close of business on October 1, 2026: (i) Thomas Wagner, co-founder and co-managing member of Knighthead, resigned from…

The Reporting Persons acquired and hold the securities of the Issuer for investment purposes. Other than as discussed herein, the Reporting Persons do not have any plans or proposals which relate to or would result in:…

Item 4 is hereby amended by adding the following to the end thereof: On August 24, 2026, the Issuer commenced a modified Dutch auction tender offer to purchase for cancellation up to US$230 million in value of its…

The Reporting Persons filed an initial Schedule 13G on February 10, 2023, which was amended on February 12, 2024; August 14, 2024; November 13, 2024 and February 12, 2025 (together, the "Schedule 13G"), with respect to…

Item 4 of the Schedule 13D is hereby amended and supplemented to include the following information: As previously disclosed, the Reporting Persons filed a consent solicitation statement on Schedule 14A with the…

The Funds acquired their respective shares for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, the Funds and other Reporting…

On August 21,2026, the Reporting Person submitted a formal notice letter to the Issuer nominating a board-member candidate with a strong background for election to the Board of Directors at the Issuer's 2026 Annual…

The Reporting Persons believe that the securities of the Issuer are undervalued and represent an attractive investment opportunity. The Reporting Persons have communicated with management and the Board of Directors of…

The information set forth in Items 3 and 6 of this Schedule 13D is incorporated herein by reference. The Reporting Persons acquired beneficial ownership of the Ordinary Shares reported herein in connection with the…

FTI acquired the Shares for investment and to facilitate the acquisition of the Issuer's commercial real estate investments. Depending upon overall market conditions, other investment opportunities available to the…

RAI has no present plans or proposals which would result in any of (b) through (j) above, but RAI is available to consider any proposal to dispose of shares at attractive prices.

Item 4 of each of the Original Schedule 13D and the Duncan Trustee Schedule 13D is hereby amended to add the paragraphs below: The information set forth under Item 3 is incorporated into this Item 4 by reference. The…

The Reporting Persons acquired the rights described in Item 3 for investment purposes. Scott Kotarba was appointed to the Issuer's board of directors (the "Board") effective August 10, 2026. Mr. Kotarba serves on the…

Almost all of the shares of Common Stock beneficially owned by the Reporting Persons were acquired prior to the Issuer's 2017 initial public offering. The Reporting Persons acquired their shares of Common Stock for…

On August 6, 2026, the Reporting Person entered into a Purchase and Sale Agreement (the "Agreement") with Kotarba Partners Fund I, LP, a Delaware limited partnership (the "Purchaser"), pursuant to which the Reporting…

On September 10, 2026, Mr. Jonas entered into a Securities Purchase Agreement with the Company and the other purchasers named therein (the "Purchase Agreement") providing for his purchase of 2,218,430 shares of Class B…

This Statement on Schedule 13D relates to the acquisition of Shares by the Reporting Persons. The Shares acquired by the Reporting Persons were acquired for the purpose of making an investment in the Issuer and not with…

Item 4 is hereby amended and supplemented by adding the following thereto: On June 12, 2026, the Court of Milan granted interim relief suspending the effectiveness of the resolution adopted at the Issuer's extraordinary…

On September 1, 2026, the Reporting Person, as one of the multiple purchasers, entered into a Securities Purchase Agreement (the "SPA") with David E. Lazar (the "Seller"), the then controlling shareholder of the Issuer,…

On September 1, 2026, the Reporting Person, as one of the multiple purchasers, entered into a Securities Purchase Agreement (the "SPA") with David E. Lazar (the "Seller"), the then controlling shareholder of the Issuer,…

Business Combination Closing On September 24, 2026 and September 25, 2026, the Issuer consummated its previously-announced business combination (the "Business Combination") with GOWell Technology Limited ("GOWell"),…

The Reporting Person acquired the shares for investment purposes. In connection with the proposed merger of Langham Merger Sub, Inc. with and into the Issuer pursuant to the Agreement and Plan of Merger dated as of July…

The Reporting Persons file the long form Schedule 13D pursuant to Section 13d-1 of the Securities Exchange Act of 1934 (the "Act") even though they may be technically eligible to file the short form Schedule G. Because…

Item 4 is hereby amended to add the following: This Amendment No. 1 is being filed to report that, following a difference of opinion with the Issuer's management regarding the Issuer's strategic direction, the Reporting…

In accordance with the terms of the Agreement and Plan of Merger by and among VerifyMe, Inc., VRME Subsidiary Corp. and Open Word Ltd. (the Merger), the Merger closed on September 30, 2026. A full description of the…

This Item 4 of the Schedule 13D is amended and supplemented as follows: As disclosed by the Issuer in the Current Report on Form 8-K filed with the Commission on September 30, 2026, Vroom Automotive, LLC, a subsidiary…

Mr. Mei Kanayama serves as Representative Director and Director of the Issuer. In such capacities, Mr. Mei Kanayama may engage in communications with the Issuer's Board of Directors, members of management, other…

On June 12, 2026, SL Bio and HSPT completed a business combination pursuant to the business combination agreement, dated May 9, 2025 (the "Business Combination Agreement"), by and among the Issuer, HSPT, CW Mega…